The Nobel laureate spent decades probing the deepest laws of nature. Now his attention has turned to a far more immediate ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that nearly 30 clinical studies of its globally first-in-class ...

“This multicenter real-world study suggests that first-line tislelizumab combined with platinum-etoposide chemotherapy provides encouraging efficacy with an acceptable safety profile in patients with ...

Spread the loveWhen the U.S. Cybersecurity and Infrastructure Security Agency, better known as CISA, issues a bulletin, it’s ...

Poster sessions at WCLC 2026 detail how surgery, nursing, and pathology can contribute to the multidisciplinary care of ...

Integrating the discussions from all six chapters of this book, we will organize a Japanese summary and an English abstract so that they can be used for book introductions, papers, and research ...

Leaps' from the Perspective of Informational Epistemology and the Continuity of Life and Consciousness〉1. Humans do not ...

If a machine can name the disease but still cannot be trusted to find it, what exactly have we bought? That is the awkward question hanging over medical AI: dazzling in the ...

The Phase 2 trial of ABCL635 (NCT07118891) is a multicenter, randomized, double-blind, placebo-controlled trial in ...

The ancient Egyptians built the pyramids with a height-to-base ratio of 1:1.618 — the Golden Ratio. The ancient Athenians, those masters of architecture, built the Parthenon with its column ...